To the Editor: Chen and colleagues1 published a risk assessment tool for type 2 diabetes (AUSDRISK) based on the Australian Diabetes, Obesity and Lifestyle Study (AusDiab).2 We tested AUSDRISK’s performance in an independent cohort of 1494 women enrolled in the Geelong Osteoporosis Study (1994–1997; 77% participation),3 comprising an age-stratified sample of women randomly selected from the Barwon Statistical Division and followed prospectively over a decade.4
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
